Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants | Biotechnology | LSA Platform

Bispecific Antibodies Potently Neutralize SARS-CoV-2 Variants | Biotechnology | LSA Platform

Powerful new antibody that neutralizes all known SARS CoV 2 variantsПодробнее

Powerful new antibody that neutralizes all known SARS CoV 2 variants

Paul Bieniasz: "SARS-CoV-2 Variants vs Antibodies: An Evolutionary Conflict"Подробнее

Paul Bieniasz: 'SARS-CoV-2 Variants vs Antibodies: An Evolutionary Conflict'

​Rapid isolation of neutralizing antibodies against SARS-CoV-2 (B. Briney)Подробнее

​Rapid isolation of neutralizing antibodies against SARS-CoV-2 (B. Briney)

BRCCH | Neutralizing SARS-CoV-2 VariantsПодробнее

BRCCH | Neutralizing SARS-CoV-2 Variants

Science of COVID-19: “The neutralizing antibody response to SARS-CoV-2”Подробнее

Science of COVID-19: “The neutralizing antibody response to SARS-CoV-2”

Engineering Optimized Anti SARS CoV 2 Antibody TherapeuticsПодробнее

Engineering Optimized Anti SARS CoV 2 Antibody Therapeutics

COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA PlatformПодробнее

COVID-19 mutant variants | Biology Solutions | High-Throughput Antibody Screening | LSA Platform

[Webinar] Combatting SARS-CoV-2 Variants: Neutralization Testing from Alpha to MuПодробнее

[Webinar] Combatting SARS-CoV-2 Variants: Neutralization Testing from Alpha to Mu

Measuring levels of SARS-CoV-2 neutralizing antibodies in individuals using a high-throughput testПодробнее

Measuring levels of SARS-CoV-2 neutralizing antibodies in individuals using a high-throughput test

Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody ScreeningПодробнее

Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody Screening

SP1-77 Neutralizes All SARS-COV-2 VariantsПодробнее

SP1-77 Neutralizes All SARS-COV-2 Variants

Rapid Discovery of Therapeutic Antibodies to Combat COVID-19 at Twist BioscienceПодробнее

Rapid Discovery of Therapeutic Antibodies to Combat COVID-19 at Twist Bioscience

Bio-Plex SARS-CoV-2 Neutralization Antibody Assays WebinarПодробнее

Bio-Plex SARS-CoV-2 Neutralization Antibody Assays Webinar

High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA PlatformПодробнее

High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA Platform

The Polytope Advantage to fight COVID-19: unlocking synergistic effects via broad epitope coverageПодробнее

The Polytope Advantage to fight COVID-19: unlocking synergistic effects via broad epitope coverage

SARS-CoV-2 Antibody DurabilityПодробнее

SARS-CoV-2 Antibody Durability

Epitope Mapping of Human Antibodies from Transgenic Chickens | Biology Solutions | LSA PlatformПодробнее

Epitope Mapping of Human Antibodies from Transgenic Chickens | Biology Solutions | LSA Platform

Generation of SARS-CoV-2 Antibodies in Multiple Formats within 4 WeeksПодробнее

Generation of SARS-CoV-2 Antibodies in Multiple Formats within 4 Weeks

Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies | High-Throughput Antibody ScreeningПодробнее

Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies | High-Throughput Antibody Screening